Mankind Pharma Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.9%1-day move

₹2580.90

prior close

₹2613.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.7+0.6+0.4-3.9-4.7-6.4-5.7-6.7-11.1-7.8-1.5-0.2—

Up moveDown movePending

AI summary

Mankind Pharma has informed exchanges that its management and officials will meet with investors in Singapore on May 25-26, 2026. This is a routine investor engagement activity under Regulation 30 of SEBI LODR regulations. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings - discussions will be limited to general business outlook and publicly available information. The meeting schedule may change due to exigencies on either side.

Likely market impact

No material impact on shareholders. This is a standard investor relations activity where no new price-sensitive information will be disclosed. Such meetings are routine for listed companies and do not indicate any major corporate development.